HOWARD GREY ELECTED TO THE NATIONAL ACADEMY OF SCIENCES

SAN DIEGO - May 7, 1999 -  Howard M. Grey, M.D., President and Scientific Director of the La Jolla Institute for Allergy and Immunology, has been elected to the National Academy of Sciences in recognition of his distinguished and continuing achievements in original research. Dr. Grey is among 60 new members and 15 foreign associates named at the 136th annual business meeting of the Academy held on April 27, 1999.

Dr. Grey is internationally recognized for his research in Immunology, in particular on the mechanisms by which foreign antigens are recognized by the immune system. He has published over 250 publications. Previous honors include the Josiah Macy Faculty Scholar Award, the Cancer Research Institute William B. Coley Award, and the Solomon A. Berson Medical Alumni Achievement Award in Basic Science from the New York University School of Medicine.

The National Academy of Sciences is a private organization of scientists and engineers dedicated to the furtherance of science and its use for the general welfare. The Academy was established in 1863 by a congressional act of incorporation, signed by Abraham Lincoln. Election to membership in the Academy is considered one of the highest honors that can be accorded a U.S. scientist or engineer.

Founded in 1988, the La Jolla Institute for Allergy and Immunology is a freestanding nonprofit research organization dedicated to the conducting of basic research relevant to the fields of Allergy and Immunology, with particular regard to the molecular and cellular mechanisms involved in the regulation of the immune system. The organization employs 200 individuals, including 94 at the M.D./Ph.D. level.

About LIAI
Founded in 1988, the La Jolla Institute for Allergy and Immunology is a nonprofit medical research center dedicated to increasing knowledge and improving human health through studies of the immune system. Scientists at the institute carry out research searching for cures for cancer, allergy and asthma, infectious diseases, and autoimmune diseases such as diabetes, inflammatory bowel disease and arthritis. LIAI's research staff includes more than 100 Ph.Ds.

###